Cigna (CI) — The Transparent Read
40/100Cautiously Bearish$275.68 · mixed
This is a stock caught in the mud. The trend is mixed, momentum is soft, and the composite score tilts bearish — but CI is defending its $268.93 support and the macro regime gives a modest edge to the upside over the next quarter. My lean is neutral-to-cautiously-constructive: don't chase it here with price under both major averages and MACD negative, but the support hold plus favorable base rate argue against aggressive bearishness. Watch how it behaves at support and whether it can reclaim the 50-day.
CI key levels
Show Your Work — every point in CI's score
The score starts at 50, then each signal below adds or subtracts points. No black box.
| Signal | Type | Points |
|---|---|---|
| Below 200-day MA Price is below its 200-day average — long-term trend is down. | technical | -8 |
| Below 50-day MA Trading below the 50-day average — medium-term momentum is weak. | technical | -5 |
| Golden cross 50-day average is above the 200-day (golden cross). | technical | +4 |
| RSI neutral RSI is 42 — neither overbought nor oversold. | technical | -0.84 |
| MACD negative MACD is below its signal line — momentum is fading. | technical | -5 |
| Near support Holding near support around $268.93. | technical | +4 |
| Macro regime base rate In 33 past periods like today (Falling inflation + Steady Fed), this stock was higher 90d later 55% of the time (median +3.4%). Historically favorable. | macro | +0.91 |
Macro regime base rate
Today's regime: Falling inflation + Steady Fed
In 33 past periods that looked like today, CI was higher 90 days later 55% of the time (median move 3.4%). Confidence: high.
The read
CI: Below the Lines but Leaning on Support
Bull case. Cigna is holding firm near support at $268.93, and the 50-day MA still sits above the 200-day (a golden cross), signaling the longer structure hasn't fully broken. The macro backdrop of falling inflation with a steady Fed is historically favorable — in 33 analogous periods, CI was higher 90 days later 55% of the time with a median gain of +3.4%. RSI at 42 leaves plenty of room to run before overbought.
Bear case. Price at $275.68 sits below both the 50-day ($283.60) and 200-day ($277.84) moving averages, telling you medium- and long-term momentum are both weak. The MACD histogram is negative at -1.45 with MACD below its signal line, so momentum is fading, not building. The composite score of 40.1/100 lands squarely in cautiously bearish territory.
What would change my mind. A decisive break below support at $268.93 flips this to outright bearish — that would confirm the downtrend and invalidate the base-rate optimism. On the flip side, a reclaim of the 50-day MA at $283.60 with MACD turning positive would shift the read to bullish.
CI — frequently asked
Is CI a buy according to Tallyread?
Tallyread does not give buy or sell recommendations. It shows a transparent 40/100 read for Cigna (CI), conditioned on today's macro regime, with every scoring input itemized so you can judge for yourself. This is not financial advice.
How is CI's Tallyread score calculated?
The 40/100 score starts at 50, then adds and subtracts named technical and macro signals — each shown with its point value and a one-line reason in the "Show Your Work" table on this page. Nothing is hidden in a black box.
How does today's Fed-and-inflation regime affect CI?
In 33 past periods whose macro regime matched today's (Falling inflation + Steady Fed), CI was higher 90 days later 55% of the time, with a median move of 3.4%. Confidence: high.
Want a fresh read on CI with the live chart and macro tape?
Run a live CI read →Last analyzed 2026-07-01 · Data source: tiingo. See the public scorecard and methodology.
This is a historical and technical read for informational and educational purposes only — not financial advice, and not a recommendation to buy or sell CI. Markets are uncertain; do your own research.